Proteoglycans and diseases of soft tissues

Advances in Experimental Medicine and Biology

Volumn 802, Issue , 2014, Pages 49-58

  Halper, Jaroslava ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Aggrecan; Collagen fibrillogenesis; Heart development; Small leucine rich proteoglycans (SLRPs); Versican

Indexed keywords

AGGRECAN; AGGRECANASE; BIGLYCAN; COLLAGEN; COLLAGEN FIBRIL; DECORIN; ELASTIN; FIBROMODULIN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; LUMICAN; PROTEOGLYCAN; VERSICAN; ADAMTS1 PROTEIN; AGGRECANASE 1; AGGRECANASE 2; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; EXTRACELLULAR MATRIX PROTEIN 2; GELATINASE A; GELATINASE B; SCLEROPROTEIN; SMALL LEUCINE RICH PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AORTA DISSECTION; AORTA VALVE STENOSIS; ARTICLE; BINDING SITE; BIOMECHANICS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; FIBROCARTILAGE; GENE MUTATION; GENETIC CODE; HUMAN; LIGAMENT DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SOFT TISSUE DISEASE; TENDON DISEASE; TENSILE STRENGTH; VALVULAR HEART DISEASE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; COLLAGEN FIBRIL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

EID: 84934444082     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-7-7893-1_4     Document Type: Article

References (85)

1. Yoon JH, Halper J (2005) Tendon proteoglycans: Biochemistry and function. J Musculoskelet Neuronal Interact 5:22-34
2. Iozzo RV (1998) Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 67:609-652
3. Carter DR, Beaupré GS (eds) (2007) Skeletal function and form. Cambridge University Press, Cambridge
4. Vogel KS, Sandy JD, Pogány G, Robbins JR (1994) Aggrecan in bovine tendon. Matrix Biol 14:171-179
5. Samiric T, Parkinson J, Ilic MZ, Cook J, Feller JA, Handley CJ (2009) Changes in the composition of the extracellular matrix in patellar tendinopathy. Matrix Biol 28:230-236
6. Engel MB, Zerlotti E (1967) Changes in cells, matrix and water of calcifying turkey leg tendons. Am J Anat 120:489-525
7. Spiesz EM, Roschger P, Zysset PK (2012) Infl uence of mineralization and microporosity on tissue elasticity: Experimental and numerical investigation on mineralized turkey leg tendons. Calcif Tissue Int 90:319-329
8. Manning PL, Morris PM, McMahon A, Jones E, Gize A, Macquaker JH, Wolff G, Thompson A, Marshall J, Taylor KG, Lyson T, Gaskell S, Reamtong O, Sellers WI, van Dongen BE, Buckley M, Wogelius RA (2009) Mineralized soft-Tissue structure and chemistry in a mummifi ed hadrosaur from the Hell Creek Formation, North Dakota (USA). Proc Biol Sci 276:3429-3437
9. Berenson MC, Blevins FT, Plaas AH, Vogel KG (1996) Proteoglycans of human rotator cuff tendons. J Orthop Res 14:518-525
10. Parkinson J, Samiric T, Ilic MZ, Cook J, Handley CJ (2011) Involvement of proteoglycans in tendinopathy. J Musculoskelet Neuronal Interact 11:86-93
11. Iozzo RV (2007) The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Mol Biol Cell 32:141-174
12. Iozzo RV, Schaefer L (2010) Proteoglycans in health and disease: Novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277:3864-3875
13. Iozzo RV (1999) The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274:18843-18846
14. Iozzo RV, Murdoch AD (1996) Proteoglycans of the extracellular environment: Clues from the gene and protein side offer novel perspectives in molecular diversity of function. FASEB J 10:598-614
15. Rada JA, Schrecengost PK, Hassell JR (1993) Regulation of corneal collagen fi brillogenesis in vitro by corneal proteoglycan (lumican and decorin) core protein. Exp Eye Res 56:635-648
16. Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H (1995) Interaction of biglycan with type I collagen. J Biol Chem 270:2776-2783
17. Schönherr E, Hausser E, Beavan L, Kresse H (1995) Decorin-Type I collagen interaction. Presence of separate core protein-binding domains. J Biol Chem 270:8877-8883
18. Svensson L, Närlid I, Oldberg Å (2000) Fibromodulin and lumican bind to the same region on collagen type I fi brils. FEBS Lett 470:178-182
19. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE (2006) Decorin regulates assembly of collagen fi brils and acquisition of biomechanical properties during tendon Development. J Cell Biochem 98:1436-1449
20. Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction. J Biol Chem 283:21305-21309
21. McEwan PA, Scott PG, Bishop PN, Bella J (2006) Structural correlations in the family of small leucinerich repeat proteins and proteoglycans. J Struct Biol 155:294-305
22. Heinegård D (2009) Proteoglycans and more - from molecules to biology. Int J Exp Pathol 70:575-586
23. Bengtsson E, Apberg A, Heinegård D, Sommarin Y, Spillmann D (2000) The amino-Terminal part of PRELP binds to heparin and heparan sulfate. J Biol Chem 275:40695-40702
24. Ohta K, Kuriyama S, Okafuji T, Gejima R, Ohnuma S, Tanaka H (2006) Tsukushi cooperates with VG1 to induce primitive streak and Hensen's node formation in the chick embryo. Development 133:3777-3786
25. Shimizu-Hirota R, Sasamura H, Kuroda M, Kobayashi E, Saruta T (2004) Functional characterization of podocan, a member of a new class in the small leucine- rich repeat protein family. FEBS Lett 563: 69-74
26. Bredrup C, Knappskog PM, Majewski J, Rødahl E, Boman H (2005) Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci 46:420-426
27. Bredrup C, Stang E, Bruland O, Palka BP, Young RD, Haavik J, Knappskog PM, Rødahl E (2010) Decorin accumulation contributes to the stromal opacities found in congenital stromal corneal dystrophy. Invest Ophthalmol Vis Sci 51:5578-5582
28. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fi bril morphology and skin fragility. J Cell Biol 136:729-743
29. Reed CC, Iozzo RV (2003) The role of decorin in collagen fi brillogenesis and skin homeostasis. Glycoconj J 19:249-255
30. Schönherr E, Broszat M, Brandan E, Bruckner P, Kresse H (1998) Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 355:241-248
31. Santra M, Reed CC, Iozzo RV (2002) Decorin binds to a narrow region of the EGF receptor, partially overlapping with, but distinct from, the EGF-binding epitope. J Biol Chem 277:35671-35681
32. Hildebrand A, Romaris M, Rasmussen IM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fi bromodulin with transforming growth beta. Biochem J 302:527-534
33. Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Maccarana M, Westergren-Thorsson G, Malmström A (2005) Regulation of the chondroitin/ dermatan fi ne structure by transforming growth factor-β1 through effects on polymer-modifying enzymes. Glycobiology 15:1277-1285
34. Kuo CK, Petersen BC, Tuan RS (2008) Spatiotemporal protein Distribution of TGFβs, their receptors, and extracellular matrix molecules during embryonic tendon Development. Dev Dyn 237:1477-1489
35. Dunkman AA, Buckley MR, Mienaltowski MJ, Adams SM, Thomas SJ, Satchell L, Kumar A, Pathmanathan L, Beason DP, Iozzo RV, Birk DE, Soslowsky LJ (2013) Decorin expression is important for age-related changes in tendon structure and mechanical properties. Matrix Biol 32:3-13
36. Ameye L, Young MF (2002) Mice defi cient in small leucine-rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12(9):107R-116R
37. Krusius T, Ruoslahti E (1986) Primary structure of an extracellular matrix proteoglycan core protein Deduced from cloned cDNA. Proc Natl Acad Sci U S A 83: 7683-7687
38. Heegaard AM, Corsi A, Danielsen CC, Nielsen KL, Jorgensen HL, Riminucci M, Young MF, Bianco P (2012) Biglycan Defi ciency causes spontaneous dissection and rupture in mice. Circulation 115: 2731-2738
39. Wiberg C, Heinegard D, Wenglen C, Timpl R, Morgelin M (2002) Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem 277:49120-49126
40. Lechner BE, Lim JH, Mercado ML, Fallon JR (2006) Developmental regulation of biglycan expression in muscle and tendon. Muscle Nerve 34:347-355
41. Rees SG, Dent CM, Caterson B (2009) Metabolism of proteoglycans in tendon. Scand J Med Sci Sports 19:470-478
42. Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Summer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF (2002) Phenotypic effects of bioblycan Defi ciency are linked to collagen fi bril abnormalities, are synergized by decorin Defi ciency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17:1180-1189
43. Ameye L et al (2002) Abnormal collagen fi brils in tendons of biglycan/fi bromodulin-defi cient mice lead to gait impairment, ectopic ossifi cation, and osteoarthritis. FASEB J 16(7):673-680
44. Young MF, Bi Y, Ameye L, Chen XD (2002) Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconj J 19:257-262
45. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF (2007) Identifi cation of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13:1219-1227
46. Bianco P, Fiaher LR, Young MF, Termine JD, Robey PG (1990) Expression and localization of the two small proteoglycans biglycan and decorin in Developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563
47. Yeo TK, Torok MA, Kraus HL, Evans SA, Zhou Y, Marcum JA (1995) Distribution of biglycan and its propeptide form in rat and bovine aortic tissue. J Vasc Res 32:175-182
48. Song R, Zeng Q, Ao L, Yu JA, Cleveland JC, Zhao KS, Fullerton DA, Meng X (2012) Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler Thromb Vasc Biol 32:2711-2720
49. Didangelos A, Mayr U, Monaco C, Mayr M (2012) Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem 287:19341-19345
50. Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA (1999) Familial patterns of thoracic aortic aneurysms. Arch Surg 134:361-367
51. Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF (1986) Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 109:820-826
52. Kalamajski S, Aspberg A, Lindblom K, Heinegård D, Oldberg Å (2009) Asporin competes with decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization. Biochem J 423:534-539
53. Ikegawa S (2008) Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr Med Chem 15:724-728
54. Hedlund H, Mengarelli-Widholm S, Heinegård D, Reinholt FP, Svensson O (1994) Fibromodulin Distribution and association with collagen. Matrix Biol 14:227-232
55. Viola M (2007) Fibromodulin interactions with type I and II collagens. Connect Tissue Res 48:141-148
56. Hedbom E, Heinegård D (1989) Interaction of a 59-dDa connective tissue matrix protein with collagen I and collagen II. J Biol Chem 264:6898-6905
57. Önnerfjord PH, Önnerfjord PH (2004) Identifi cation of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J Biol Chem 279:26-33
58. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H (1998) Lumican regulates collagen fi bril assembly: Skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141:1277-1286
59. Svensson L, Aszódi A, Reinholt FP, Fässler R, Heinegård D, Oldberg A (1999) Fibromodulin-null mice have abnormal collagen fi brils, tissue organization, and altered lumican Deposition in tendon. J Biol Chem 274:9636-9647
60. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg Å, Birk DE, Chakravarti S (2002) A syndrome of joint laxity and impaired joint integrity in lumican- And fi bromodulin-defi cient mice. J Biol Chem 277:35532-35540
61. Day JM, Olin AL, Murdoch AD, Canfi eld A, Sasaki T, Timpl R, Hardingham TE, Aspberg A (2004) Alternative splicing in the aggrecan G3 domain infl uences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem 279:12511-12518
62. Stattin EL, Wiklund F, Lindblom K, Onnerfjord P, Jonsson BA, Tegner Y, Sasaki T, Struglics A, Lohmander S, Dahl N, Heinegård D, Aspberg A (2010) A missense mutation in the aggrecan C-Type lectin Domain Disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet 86:126-137
63. Valhmu WB, Stazzone EJ, Bachrach NM, Saed-Nejad F, Fischer SG, Mow VC, Ratcliffe A (1998) Loadcontrolled compression of articular cartilage induces a transient stimulation of aggrecan gene expression. Arch Biochem Biophys 353:29-36
64. Ström A, Ahlqvist E, Heinegård D, Franzen A, Hultgårdh-Nilsson A (2004) Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor defi cient mice: An immunohistochemical study. Histol Histopathol 19:337-347
65. Munteanu SE, Ilic MZ, Handley CJ (2002) Highly sulfated glycosminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant culture. Matrix Biol 21:429-440
66. Rees SG, Flannery CR, Little CB, Hughes CE, Caterson B, Dent CM (2000) Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J 350:181-188
67. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ (2003) IL-1 beta induces COX2, MMP-1,-3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 21:256-264
68. Plaas A, Sandy JD, Liu H, Diaz MA, Schenkman D, Magnus RP, Bolam-Bretl C, Kopesky PW, Wang VM, Galante JO (2011) Biochemical identifi cation and immunolocalization of aggrecan, ADAMTS5 and inter-Alpha-Trypsin-inhibitor in equine degenerative suspensory ligament desmitis. J Orthop Res 29:900-906
69. Samiric T, Ilic MZ, Handley CJ (2004) Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 23:127-140
70. Wight T (2002) Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14:617-623
71. Zhang Y, Cao L, Kiani C, Yang BL, Hu W, Yang B (1997) Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motif. J Cell Biochem 73:445-457
72. Corps AN, Jones GC, Harrall RL, Curry VA, Hazleman BL, Riley GP (2008) The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol 27:393-401
73. Aspberg A, Adam S, Kostka G, Timpl R, Heinegård D (1999) Fibulin-1 is a ligand for the C-Type lectin Domains of aggrecan and versican. J Biol Chem 274:20444-20449
74. Olin AI, Mörgelin M, Sasaki T, Timpl R, Heinegård D, Aspberg A (2001) The proteoglycans aggrecan and versican form networks with fi bulin-2 through their lectin Domain binding. J Biol Chem 276:1253-1261
75. Wu YJ, Lapierre D, Wu J, Yee AJ, Yang BB (2005) The interaction of versican with its binding partners. Cell Res 15:483-494
76. Choocheep K, Hatano S, Takagi H, Watanabe H, Kimata K, Kongtawelert P, Watanabe H (2010) Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem 285:21114-21125
77. Hinton RBJ, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE (2006) Extracellular matrix remodeling and organization in Developing and diseased aortic valves. Circ Res 98:1431-1438
78. Lincoln J, Lange AW, Yutzey KE (2006) Hearts and bones: Shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol 294:292-302
79. Shelton EL, Yutzey KE (2008) Twist1 function in endocardial cushion cell proliferation, migration, and differentiation During heart valve development. Dev Biol 317:282-295
80. Shelton EL, Yutzey KE (2007) Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol 302:376-388
81. Krishnamurthy VK, Opoka AM, Kern CB, Guilak F, Narmoneva DA, Hinton RB (2012) Maladaptive matrix remodeling and regional biomechanical dysfunction in a mouse model of aortic valve disease. Matrix Biol 31:197-205
82. Visse MR, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92:827-839
83. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202:56-66
84. Hatano S, Kimata K, Hiraiwa N, Kusakabe M, Isogai Z, Adachi E, Shinomura T, Watanabe H (2012) Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion Development. Glycobiology 22:1268-1277
85. Huang R, Merrilees MJ, Braun K, Beaumont B, Lemire J, Clowes AW, Hinek A, Wight TN (2006) Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fi ber formation in vitro and in neointima after vessel injury. Circ Res 98:370-377